Actualités ac155/617
1996 Demag AC155 All Terrain CRane - REMOVED
Fri, 03 Jul 2020 04:37:00 GMT
- Product Description XCA2600, the world s largest tonnage all-terrain crane developed by XCMG, has successfully completed the first test lift, a 173-ton weight. The XCA2600 is equipped with three ...
617 Squadron
Tue, 24 Oct 2023 07:02:00 GMT
617 Squadron is based at RAF Marham. The Squadron adopted its name and badge after the famous Dams Raid in 1943. Previous aircraft flown include the Avro Lancaster, Lincoln and Vulcan; English ...
What Happened To RAF 617 Squadron After The Dambusters Raid
Sun, 23 Jul 2023 02:10:00 GMT
After the success of the Ruhr dams raid in May 1943, 617 Squadron was retained by RAF Bomber Command for specialist precision bombing operations. It experimented with new bomb sights, target marking ...
The Incredible Story Of The Dambusters Raid
Tue, 06 Jun 2023 09:28:00 GMT
The surviving aircrew of 617 Squadron were lauded as heroes, and Guy Gibson was awarded the Victoria Cross for his actions during the raid. The raid also established 617 Squadron as a specialist ...
DWP sending £617 into bank accounts 'earlier than normal' this December
Fri, 08 Nov 2024 07:09:00 GMT
Universal Credit is paid to low-income households up to a maximum of £617.60 per month, depending on your circumstances. You’ll get this top rate if you live with your partner and either of you ...
Pluvicto™ (formerly 177Lu-PSMA-617)
Mon, 03 Dec 2018 00:52:00 GMT
Pluvicto™ (formerly 177Lu-PSMA-617) is a radioligand therapy that was approved by the FDA in March 2022 to treat progressive, PSMA positive metastatic castration-resistant prostate cancer. Pluvicto™ ...
ESMO 2023: PSMAfore Phase 3 Trial of [177Lu]Lu-PSMA-617 in Taxane-Naive Patients with Metastatic Castration Resistant Prostate Cancer
Wed, 13 Dec 2023 21:41:00 GMT
(UroToday.com) The 2023 ESMO annual meeting included a Presidential session, featuring a presentation by Dr. Oliver Sartor discussing results of PSMAfore, a phase 3 trial of 177 Lu-PSMA-617 in ...
GU Oncologists Anticipate Earlier Role of Lutetium-177 PSMA-617 in Prostate Cancer
Sun, 13 Oct 2024 17:00:00 GMT
As oncologists are seeing the impact of 177 Lu-PSMA-617 in the mCRPC setting, new research data are showing promise for using this drug in other settings. This would meet the need for tolerable ...
Synthesis and Preclinical Evaluation of a Bispecific PSMA-617/RM2 Heterodimer Targeting Prostate Cancer
Thu, 17 Oct 2024 17:00:00 GMT
Radiochemical Studies Laboratory, INRASTES, N.C.S.R. “Demokritos”, Agia Paraskevi Attikis, 15310 Athens, Greece Institute of Pharmaceutical Research & Technology (IFET), 18th km of Marathonos Avenue, ...
617 Squadron Reborn
Mon, 05 Feb 2024 08:14:00 GMT
The new Officer Commanding No 617 Sqn, Wg Cdr John Butcher, took his first flight in an F-35B Lightning, the UK’s new multi-role stealth combat aircraft. The standing up of 617 Sqn (designated as the ...